Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0002049575-25-000002·V-CO Investors LLC
Schedule 13D ownership disclosure
VIVOS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 92859E207
Event date: 2025-06-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- V-CO Investors LLCReported CIK 0002049575
Shares: 514,498.00 · Class: 7.7%
- V-Co Investors 2 LLC
Shares: 828,000.00 · Class: 12.3%
- SP Manager LLC
Shares: 1,342,498.00 · Class: 19.9%
- Michael C. Skaff
Shares: 1,342,498.00 · Class: 19.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002049575-25-000002
- Form type
- SCHEDULE 13D
- Filer
- V-CO Investors LLC
- CIK
- CIK 2049575
- Filed
- Jun 16, 2025
- Reporting period
- Jun 09, 2025
- Description
- Schedule 13D beneficial ownership